Juvenile Idiopathic Arthritis
Özet
Juvenile idiopathic arthritis (JIA) is an illness which begins before the age of 16 and is characterized by arthritis in the same joint for at least six weeks. JIA is a diagnosis considered after other causes of arthritis have been ruled out. Cardiac symptoms in JIA may vary according to the region affected by inflammation. In some patients, symptoms consistent with the inflammation of the pericardium, which is one of the serous membranes, may appear, while in another patient group, the coronary arteries or the conduction system of the heart may be affected. In our article, JIA subtypes are described and their cardiac involvements are determined.
Referanslar
Tse SM, Laxer RM. Approach to acute limb pain in childhood. Pediatr Rev. 2006 May;27(5):170-9; quiz 180. doi: 10.1542/pir.27-5-170. PMID: 16651274.
Siegel DM. Chronic arthritis in adolescence. Adolesc Med State Art Rev. 2007 May;18(1):47-61, viii. PMID: 18605390.
Rossiter DJ, Ahluwalia A, Vo P, Mapara R. The limping child: a systematic approach to assessment and management. Br J Hosp Med (Lond). 2018 Oct 2;79(10):C150-C153. doi: 10.12968/hmed.2018.79.10.C150. PMID: 30290754.
National Institute for Health and Care Excellence. 2015. Acute Childhood Limp. (Accessed 19 September 2018) https://cks.nice.org.uk/acute- childhood-limp
Foster HE, Jandial S. pGALS - paediatric Gait Arms Legs and Spine: a simple examination of the musculoskeletal system. Pediatr Rheumatol Online J. 2013 Nov 12;11(1):44. doi: 10.1186/1546-0096-11-44. PMID: 24219838; PMCID: PMC4176130.
Riise ØR, Handeland KS, Cvancarova M, et al. Incidence and Characteristics of Arthritis in Norwegian Children: A Population-Based Study. Pediatrics. 2008 Feb;121(2): e299-306. doi: 10.1542/peds.2007-0291. Epub 2008 Jan 28. PMID: 18227193.
Petty RE, Laxer RM. Juvenile Idiopathic Arthritis: Classification and Basic Concepts, In: Petty RE, Laxer RM (Eds): Textbook of Pediatric Rheumatology. 8th ed. W.B. Saunders, Philadelphia 2020:209-215.
Shirley ML Tse, Colbert RA. Enthesitis-Related Arthritis, In: Petty RE, Laxer RM (Eds): Textbook of Pediatric Rheumatology. 8th ed. W.B. Saunders, Philadelphia 2020:250-267.
Petty RE, Laxer RM, Lindsley CB, Wedderburn lR. Juvenile Idiopathic Arthritis. Textbook of Pediatric Rheumatology. 7 th ed. Elsevier Health Sciences. 2015. p. 188-284.
Adams A, Lehman TJ. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2005 Sep;17(5):612-6. doi: 10.1097/01.bor.0000169363.69066.d0. PMID: 16093841.
Martini A, Ravelli A, Avcin T, et al. Pediatric Rheumatology International Trials Organization (PRINTO). Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2019 Feb;46(2):190-197. doi: 10.3899/jrheum.180168. Epub 2018 Oct 1. PMID: 30275259.
Aaron S, Fraser PA, Jackson JM, et al. Sex ratio and sibship size in juvenile rheumatoid arthritis kindreds. Arthritis Rheum. 1985 Jul;28(7):753-8. doi: 10.1002/art.1780280705. PMID: 4015722.
Kaya Akca U, Batu ED, Sener S, et al. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study. Clin Rheumatol. 2022 Jun;41(6):1785-1792. doi: 10.1007/s10067-022-06080-8. Epub 2022 Jan 29. PMID: 35091782.
Prahalad S. Genetics of juvenile idiopathic arthritis: an update. Curr Opin Rheumatol. 2004 Sep;16(5):588-94. doi: 10.1097/01.bor.0000134407.48586.b0. PMID: 15314499.
Massa M, Mazzoli F, Pignatti P, et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum. 2002 Oct;46(10):2721-9. doi: 10.1002/art.10564. PMID: 12384932.
Barnes MG, Grom AA, Thompson SD, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum. 2010 Nov;62(11):3249-58. doi: 10.1002/art.27657. PMID: 20662067; PMCID: PMC3018072.
Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011 Jun 7;7(7):416-26. doi: 10.1038/nrrheum.2011.68. PMID: 21647204; PMCID: PMC4180659.
Ravelli A, Minoia F, Davì S, et al; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9. PMID: 26314788..
Karmacharya P, Balls-Berry JE, Davis JM 3rd. True Difference or Detection Bias: Racial Differences in Clinical Features and Comorbidities in Ankylosing Spondylitis in the United States. J Rheumatol. 2020 Jul 1;47(7):1150. doi: 10.3899/jrheum.191399. Epub 2020 Feb 15. PMID: 32062596.
Akdeniz B, Akyel N, Yildiz M, et al. Comparison of the efficacy of physical examination and radiological imaging in detecting sacroiliitis in patients with juvenile spondyloarthropathies. Clin Exp Rheumatol. 2020 Sep-Oct;38(5):1021-1028. Epub 2020 Mar 13. PMID: 32167879.
van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. PMID: 28087505.
Gouveia EB, Elmann D, Morales MS. Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol. 2012 Oct;52(5):742-56. English, Portuguese. PMID: 23090374.
Liew JW, Ramiro S, Gensler LS. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):369-389. doi: 10.1016/j.berh.2019.01.002. Epub 2019 Mar 6. PMID: 31171309.
Nigrovic PA, Sundel RP. Juvenile psoriatic Arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn lR. Textbook of pediatric Rheumatology. 7th ed. Philadelphia: Elsevier. 2016.p.375-91.
Stoll ML, Zurakowski D, Nigrovic LE, et al. Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis Rheum. 2006 Nov;54(11):3564-72. doi: 10.1002/art.22173. PMID: 17075862.
Giancane G, Consolaro A, Lanni S, et al. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther. 2016 Dec;3(2):187-207. doi: 10.1007/s40744-016-0040-4. Epub 2016 Aug 12. PMID: 27747582; PMCID: PMC5127964.
Giancane G, Alongi A, Rosina S, et al. Recent therapeutic advances in juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2017 Aug;31(4):476-487. doi: 10.1016/j.berh.2018.01.001. Epub 2018 Feb 26. PMID: 29773268.
Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460. PMID: 21452260; PMCID: PMC3222233.
Schiappapietra B, Varnier G, Rosina S, et al. Glucocorticoids in juvenile idiopathic arthritis. Neuroimmunomodulation. 2015;22(1-2):112-8. doi: 10.1159/000362732. Epub 2014 Sep 12. PMID: 25227183.
Batu ED. Glucocorticoid treatment in juvenile idiopathic arthritis. Rheumatol Int. 2019 Jan;39(1):13-27. doi: 10.1007/s00296-018-4168-0. Epub 2018 Oct 1. PMID: 30276425.
Ansell BM, Hall MA, Loftus JK, et al. A multicentre pilot study of sulphasalazine in juvenile chronic arthritis. Clin Exp Rheumatol. 1991 Mar-Apr;9(2):201-3. PMID: 1676352.
Vojinović J, Foeldvari I, Dehoorne J, et al; Paediatric Rheumatology International Trials Organisation (PRINTO). Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis. Rheumatology (Oxford). 2023 May 4:kead183. doi: 10.1093/rheumatology/kead183. Epub ahead of print. PMID: 37140539.
Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018 Mar;77(3):336-342. doi: 10.1136/annrheumdis-2017-212104. Epub 2017 Nov 14. PMID: 29138257; PMCID: PMC5867401.
Shepherd J, Cooper K, Harris P, et al. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. Health Technol Assess. 2016 Apr;20(34):1-222. doi: 10.3310/hta20340. PMID: 27135404; PMCID: PMC4867422.
Vastert SJ, de Jager W, Noordman BJ, et al. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol. 2014 Apr;66(4):1034-43. doi: 10.1002/art.38296. PMID: 24757154.
Orrock JE, Ilowite NT. Canakinumab for the treatment of active systemic juvenile idiopathic arthritis. Expert Rev Clin Pharmacol. 2016 Aug;9(8):1015-24. doi: 10.1080/17512433.2016.1204910. Epub 2016 Jul 6. PMID: 27367267.
Demir S, Sönmez HE, Arslanoğlu-Aydın E, et al. Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience. Turk J Pediatr. 2019;61(2):180-185. doi: 10.24953/turkjped.2019.02.005. PMID: 31951328.
Lefèvre-Utile A, Galeotti C, Koné-Paut I. Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Joint Bone Spine. 2014 May;81(3):257-9. doi: 10.1016/j.jbspin.2013.09.004. Epub 2014 May 1. PMID: 24793086.
Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki Disease and COVID-19. Mediterr J Rheumatol. 2020 Sep 21;31(Suppl 2):268-274. doi: 10.31138/mjr.31.3.268. PMID: 33196004; PMCID: PMC7656130.
Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994 Jan;89(1):252-7. doi: 10.1161/01.cir.89.1.252. PMID: 8281654.
Bohr AH, Fuhlbrigge RC, Pedersen FK, et al. Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J. 2016 Jan 6;14(1):3. doi: 10.1186/s12969-015-0061-5. PMID: 26738563; PMCID: PMC4704268.
Yeh KW, Lee CM, Chang CJ, et al. Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment. PLoS One. 2014 Mar 6;9(6):e90757. doi: 10.1371/journal.pone.0090757. PMID: 24603504; PMCID: PMC3948338.
Madenidou AV, Mavrogeni S, Nikiphorou E. Cardiovascular Disease and Cardiac Imaging in Inflammatory Arthritis. Life (Basel). 2023 Mar 30;13(4):909. doi: 10.3390/life13040909. PMID: 37109438; PMCID: PMC10143346.
Jiménez-Balderas FJ, García-Rubi D, Pérez-Hinojosa S, et al. Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology. 2001 Aug;52(8):543-8. doi: 10.1177/000331970105200806. PMID: 11512693.
